Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer

摘要

the invention relates to the application combinatiilor coordinative in medicine is the use of (m - aqua) - bis (i tricloracetato) - tri (aqua) cobalt aqua cobalt bis (tricloracetato) monohydrate as inhibitor of human myeloid leukaemia.the essence of the invention lies in that as the inhibitor of human myeloid leukaemia's claim (m - aqua) - bis (i tricloracetato) - tri (aqua) cobalt aqua cobalt bis (tricloracetato) monohydrate with formula: the invention consist in determining the (m - aqua) - bis (i tricloracetato) - tri (aqua) cobalt aqua cobalt bis (tricloracetato) monohydrate anticancer activity, which exceeds 1,25...1,35 times characteristics of dimerilor analogues trihidratului aquaetilendiamintetraacetatobismutatului (iii) 1,6 - dinitrotetraamincobalt (iii) and (iii) dihidratului etilendiamintetraacetatobismutatului oxalatotetraamincobalt (iii) (analogue).